Loading...
North American cost analysis of brand name versus generic drugs for the treatment of glaucoma
BACKGROUND: According to the World Health Organization, glaucoma is a leading cause of irreversible blindness worldwide. By 2020, 80 million people will be affected by glaucoma in the world, which represents a significant financial burden to society. Glaucoma medications alone make up 38–52% of the...
Na minha lista:
| Udgivet i: | Clinicoecon Outcomes Res |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6924989/ https://ncbi.nlm.nih.gov/pubmed/31908505 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S156558 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|